INTERNATIONAL MEDICAL DEVELOPMENT LIMITEDActive

Company number 10028041Private limited companyIncorporated 2016

Key figures

£3-99.9%
Net assets 2025/26
+0.0%
Average annual growth 2020/21–2025/26
-20 k020 k40 k60 k2020/212021/222023/242024/252025/26

Like most small UK companies, INTERNATIONAL MEDICAL DEVELOPMENT LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0100 k200 k300 k2020/212021/222023/242024/252025/26
Filed accounts2020/21–2025/26
2020/212021/222023/242024/252025/26
Cash at bank and in hand103,131868175,53513,19525,645
Total assets245,546234,038176,796111,965119,597
Total liabilities245,836250,929133,575107,203119,594
Net assets / total equity3-16,89143,2214,7623
Average number of employees11110

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: INTERNATIONAL MEDICAL DEVELOPMENT LIMITED

Company

INTERNATIONAL MEDICAL DEVELOPMENT LIMITED is a private limited company registered with Companies House under company number 10028041. It was incorporated on 26 Feb 2016. Its status is active. The registered office is in London (SM2). Its nature of business (SIC 2007) is other human health activities (86900).

Accounts

The latest accounts in the database are for 2025/26 (period ending 31 Mar 2026); the company files small company accounts (filleted). Net assets were £3, down 99.9% on the previous year. Cash at bank and in hand was £25,645. Total assets were £119,597 and total liabilities £119,594. The company had an average of 0 employees. Figures are available for 5 financial years (2020/21–2025/26).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Dec 2027. The next confirmation statement is due by 22 Feb 2027.